Pharmacological enhancement of slow-wave activity at an early disease stage improves cognition and reduces amyloid pathology in a mouse model of Alzheimer's disease.

Front Aging Neurosci · 2024 · PMC11739298 · PMID 39831085

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

showed a trendp = 0.079so close (0.05 < p ≤ 0.1)

Our analyses showed a trend toward a positive correlation between delta activity gain and cognitive performance in the early intervention group [ n = 8, r pb (6) = 0.653, r b = 0.819, p = 0.079, Figure 4A ], while there was no apparent correlation in the late intervention group [ n = 9, r pb (7) = 0.563, r b = 0.786, p = 0.11

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.